The trajectory of companies tied to blockbuster drugs like Viagra presents a challenging investment scenario . While the initial rise of copyright, fueled by Viagra's remarkable popularity, generated substantial profits , the patent expiration in key regions has introduced considerable volatility. Investors are now assessing the consequences of riv